Works matching IS 1470269X AND DT 2014 AND VI 14 AND IP 2

Results: 13

The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancer.

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 115, doi. 10.1038/tpj.2013.19

By:

Hagleitner, M M;
Coenen, M J H;
Aplenc, R;
Patiño-Garcia, A;
Chiusolo, P;
Gemmati, D;
De Mattei, M;
Ongaro, A;
Krajinovic, M;
Hoogerbrugge, P M;
Vermeulen, S H H M;
te Loo, D M W M

Publication type:

Article

Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder.

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 176, doi. 10.1038/tpj.2013.12

By:

Brandl, E J;
Tiwari, A K;
Zhou, X;
Deluce, J;
Kennedy, J L;
Müller, D J;
Richter, M A

Publication type:

Article

Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype dependent.

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 151, doi. 10.1038/tpj.2013.17

By:

Michaud, V;
Kreutz, Y;
Skaar, T;
Ogburn, E;
Thong, N;
Flockhart, D A;
Desta, Z

Publication type:

Article

HIBAG-HLA genotype imputation with attribute bagging.

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 192, doi. 10.1038/tpj.2013.18

By:

Zheng, X;
Shen, J;
Cox, C;
Wakefield, J C;
Ehm, M G;
Nelson, M R;
Weir, B S

Publication type:

Article

Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 171, doi. 10.1038/tpj.2013.26

By:

Bluett, J;
Ibrahim, I;
Plant, D;
Hyrich, K L;
Morgan, A W;
Wilson, A G;
Isaacs, J D;
Barton, A

Publication type:

Article

Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians.

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 120, doi. 10.1038/tpj.2013.10

By:

Liu, X;
Cheng, D;
Kuang, Q;
Liu, G;
Xu, W

Publication type:

Article

Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence.

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 142, doi. 10.1038/tpj.2013.20

By:

Páez, D;
Gerger, A;
Zhang, W;
Yang, D;
Labonte, M J;
Benhanim, L;
Kahn, M;
Lenz, F;
Lenz, C;
Ning, Y;
Wakatsuki, T;
Loupakis, F;
Lenz, H-J

Publication type:

Article

Functional characterization of 32 CYP2C9 allelic variants.

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 107, doi. 10.1038/tpj.2013.22

By:

Niinuma, Y;
Saito, T;
Takahashi, M;
Tsukada, C;
Ito, Mi;
Hirasawa, N;
Hiratsuka, M

Publication type:

Article

Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS).

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 182, doi. 10.1038/tpj.2013.16

By:

Beech, R D;
Leffert, J J;
Lin, A;
Sylvia, L G;
Umlauf, S;
Mane, S;
Zhao, H;
Bowden, C;
Calabrese, J R;
Friedman, E S;
Ketter, T A;
Iosifescu, D V;
Reilly-Harrington, N A;
Ostacher, M;
Thase, M E;
Nierenberg, A

Publication type:

Article

Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapy.

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 135, doi. 10.1038/tpj.2013.21

By:

Benhaim, L;
Gerger, A;
Bohanes, P;
Paez, D;
Wakatsuki, T;
Yang, D;
LaBonte, M J;
Ning, Y;
El-Khoueiry, R;
Loupakis, F;
Zhang, W;
Laurent-Puig, P;
Lenz, H J

Publication type:

Article

Gene expression analysis in RA: towards personalized medicine.

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 93, doi. 10.1038/tpj.2013.48

By:

Burska, A N;
Roget, K;
Blits, M;
Soto Gomez, L;
van de Loo, F;
Hazelwood, L D;
Verweij, C L;
Rowe, A;
Goulielmos, G N;
van Baarsen, L G M;
Ponchel, F

Publication type:

Article

The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 130, doi. 10.1038/tpj.2013.15

By:

Absenger, G;
Benhaim, L;
Szkandera, J;
Zhang, W;
Yang, D;
Labonte, M J;
Pichler, M;
Stotz, M;
Samonigg, H;
Renner, W;
Gerger, A;
Lenz, H-J

Publication type:

Article

Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent.

Published in:

Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 160, doi. 10.1038/tpj.2013.13

By:

Aminkeng, F;
Ross, C J D;
Rassekh, S R;
Brunham, L R;
Sistonen, J;
Dube, M-P;
Ibrahim, M;
Nyambo, T B;
Omar, S A;
Froment, A;
Bodo, J-M;
Tishkoff, S;
Carleton, B C;
Hayden, M R

Publication type:

Article